Skip to main content
EL logo

EL · Estee Lauder Companies Inc

Track EL — free
$102.25 +0.48 (+0.47%)
Market Cap
$36.87B
Shares
362.33M
Volume · Nov 20 665.99K Avg daily vol (3M) 3.4M

Price & Indicators

 

Key stats

Close
$101.77
Thu 19 Nov
Open
$103.34
Thu 19 Nov
Average volume, 30 days
3.6M
shares a session
Short interest
6.9M
1.9% of shares · 1.9 days to cover
Day range
$101.66$104.40
Open $103.34 Close $101.77
52-week closing range
$67.23$119.61
Close $101.77 14.9% under the high
Short volume, last session
39%
Last earnings
Nov 2, 2026
Latest filing
10-Q · Nov 2
Price history
Jan 2020 to Nov 2026

Up next

Feb 3, 2027 Scheduled · in 11 wks

Latest documents

2026
Nov 4
Investor event
Fiscal 27 outlook raised after 6% organic sales growth

Estee Lauder Companies reported first-quarter organic sales growth of 6% and expects fiscal 27 reported sales growth of 5% to 6.5% with operating margin of 12.9% to 13.7%.

Read from the first part of this long document
5 source passages
I lead the Investor Relations team at Estee Lauder Companies. Now, fiscal 27 is off to a strong start. Reported sales grew 7%. Organic sales increased 6%. We now expect reported sales growth of 5% to 6.5%, organic sales growth of 4% to 5.5%, operating margin expansion of 170 to 250 basis points to 12.9% to 13.7%. we have raised our outlook across the board. Open the document at this passage
Nov 4
Current report 8-K
Fiscal 2030 target: 16.5%-18.5% adjusted operating margin

On November 4, 2026, The Estée Lauder Companies Inc. announced fiscal 2030 targets of sustainable mid-single-digit organic net sales growth annually, double-digit adjusted diluted net earnings per share growth and adjusted operating margin of 16.5%-18.5%.

Regulation FD disclosure Read from the first part of this long document
2 source passages
New York, November 4, 2026 - The Estée Lauder Companies Inc. (NYSE: EL) today announced its fiscal 2030 ambition at its Capital Markets Experience: China Ecosystem Immersion event in Shanghai, China. Today, with growing confidence in the strength of Beauty Reimagined and the impact of our One ELC operating model, we are introducing our fiscal 2030 ambition: to deliver sustainable mid-single-digit organic sales growth annually and double-digit adjusted EPS growth through fiscal 2030, while achieving an adjusted operating margin of 16.5%-18.5% in fiscal 2030. Open the document at this passage
Nov 2
Quarterly report 10-Q FY2027 Q1, ended Sep 30
Net sales rose 7%, operating income reached $408 million

Estée Lauder Companies Inc. reported net sales of $3,715 million and operating income of $408 million for the three months ended September 30, 2026; net sales rose 7%.

Revenue $3.72B ▲ 6.7% Net income $233M ▲ 395.7% Diluted EPS $0.64 ▲ 392.3%
Read from the MD&A section
4 source passages
The Estée Lauder Companies Inc. is one of the world’s leading manufacturers, marketers and sellers of quality skin care, makeup, fragrance and hair care products. | Net sales | 3,715 | 100.0% | 3,481 | 100.0% | | Operating income | 408 | 11.0 | 169 | 4.9 | Reported net sales increased 7% for the three months ended September 30, 2026, driven by the increase from volume of 7% and the favorable impact from foreign currency translation of 1%. Open the document at this passage
Nov 2
Earnings call
Organic growth reaches 6% and fiscal 2027 outlook rises

Estee Lauder reported 6% organic sales growth, raised fiscal 2027 organic sales growth guidance to 4% to 5.5%, and now expects operating margin expansion of 170 to 250 basis points and diluted EPS of $3.20 to $3.45.

6 source passages
Our first quarter performance marks an overpowerful step forward for the Estee Lauder companies. Reported sales increased 7% and organic sales rose 6%. With the strong first quarter result, today we are raising our fiscal 2027 outlook. For organic sales growth, we now expect to deliver 4% to 5.5% For operating margin, we now expect 170 to 250 basis point expansion Diluted EPS is now expected to range between $3.20 to $3.45 Open the document at this passage
Nov 2
Current report 8-K
Raises Fiscal 2027 Full-Year Outlook on Sales, Margin and EPS

The Estée Lauder Companies reported fiscal 2027 first-quarter net sales up 7% to $3.7 billion and raised its full-year outlook, now assuming organic net sales growth of 4.0% to 5.5%.

Financial results
4 source passages
Our first quarter of fiscal 2027 marks another powerful step forward for The Estée Lauder Companies. As Reported Net sales increased 7% to $3.7 billion. Organic Net sales increased 6%. Raises Fiscal 2027 Full-Year Outlook on Sales, Margin and EPS Organic net sales growth of 4.0% to 5.5%, ranging from the mid-point to above the high-end of the previously communicated range of 3% to 5% Open the document at this passage
All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$15.28B
Trailing 12 months
Net income (TTM)
$368.00M
Trailing 12 months
Revenue growth YoY
+6.7%
Year over year
Operating margin
6.7%
Trailing 12 months
P / E (TTM)
100.8
Trailing earnings · reciprocal yield 1.0%
FCF yield
4.1%
TTM · current market cap
Return on invested capital
6.2%
Trailing 12 months
Net cash
−$4.05B
Latest balance sheet
Dividend yield
1.4%
Trailing 12 months
Shares change YoY
+0.8%
Year over year · more shares
Price change (1Y)
+18.5%
Trailing year
Short interest
1.9%
Latest settlement · 1.9 days to cover
View all 125 metrics

AI Brief

Q4 FY26 earnings call · Aug 19, 2026
Q4 FY26

TL;DR. Estée Lauder returned to organic sales growth in fiscal 2026 (+3% full year, +5% in Q4) with adjusted operating margin expanding 320 bps to 11.2% and adjusted diluted EPS up 66%, while raising its fiscal 2027 adjusted operating margin outlook to 12.7%–13.5% and affirming 3%–5% organic sales growth guidance; operating cash flow guidance, however, is being lowered to $1.3–1.4B for fiscal 2027.

Bullish
  • + Raised fiscal 2027 adjusted operating margin outlook to 12.7%–13.5% from prior 12.5%–13.0%.
  • + Jo Malone London and TOM FORD joined the billion-dollar brand club, bringing the portfolio to six.
  • + Strong performance in China with 9% organic growth and share gains across categories.
Bearish
  • − Hair Care organic net sales declined 1% in fiscal 2026.
  • − Makeup adjusted operating results decreased to a loss position in fiscal 2026.
  • − Fiscal 2027 net cash flows from operations guided to $1.3–$1.4B, down from $1.77B in fiscal 2026.

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Neutral Momentum Neutral Sentiment Neutral Fundamentals Strong Quant / Vol Very High
Market backdrop VIX 28.4 · fear Equity put/call 0.62
Technical
price trend
Neutral
50 / 200-day cross No cross
Price vs 200-day avg +12%
above
Price vs 50-day avg −0%
below
RSI (14) 42
neutral
MACD trend Negative
52-week position 66%
mid-range
Momentum
relative strength
Neutral
1-month return −6%
trailing
6-month return +19%
trailing
YTD return −3%
this year
Relative strength +25%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $102 › 200d $91 — 50d above 200d
Institutional flow Accumulating
+9% holders QoQ · +154 funds added
Insider flow Distributing
Net -$24.6M over 90 days · 100% sells
Short interest Falling
1.90% of shares out · ▼ -2.5% MoM · 1.9 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
917 holders — mid 3-yr range
Squeeze score 49
elevated · 0–100
Fundamentals
Strong
Revenue growth +5%
Y/Y
Gross margin 76%
expanding
EPS growth +116%
Y/Y
Free cash flow $1.3B
Valuation P/E 100.8
rich
Balance sheet $3.8B
net debt
Quant / Vol
risk profile
Very High
Volatility 48%
annualized · 1-yr
Max drawdown −44%
past year
ATR 3.9%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Beat or met 5 of last 7
Latest guidance · from the 8-K filed Nov 2, 2026
fiscal 2027 full-year
Organic net sales growth Raised 4% – 5.5%
Aug 19, 2026 3% – 5% changed to Nov 2, 2026 4% – 5.5%
Adjusted operating margin Raised 12.9% – 13.7%
Aug 19, 2026 12.7% – 13.5% changed to Nov 2, 2026 12.9% – 13.7%
Adjusted effective tax rate Maintained 33% – 34%
Aug 19, 2026 33% – 34% changed to Nov 2, 2026 33% – 34%
Net cash flows provided by operating activities Raised $1.4B – $1.5B
Aug 19, 2026 $1.3B – $1.4B changed to Nov 2, 2026 $1.4B – $1.5B
Capital expenditures 4%
Twelve Months Ending June 30, 2027
As Reported - GAAP 5% – 6.5%
Forecasted/As Reported EPS - GAAP $2.85 – $3.18
prior FY $0.50 midpoint +503.0% Y/Y
Previous outlook earlier release · from the 8-K filed Aug 19, 2026

Still-open targets the latest release did not restate under the same label.

As Reported - GAAP net sales growth · Twelve Months Ending June 30, 2027(F) 3% – 5%
Organic Net Sales · Twelve Months Ending June 30, 2027 3% – 5%
Prior guidance period ended · from the Earnings Call filed May 1, 2026
Organic sales growth · fiscal 26 3%
Operating margin · full year 10.7% – 11%
Guided vs delivered · last 7 settled
Reported diluted net earnings per common share Full Year Fiscal 2025
guided $2.52 – $2.76
$-3.15 Miss −219.3%
Reported diluted net earnings per common share Twelve Months Ending June 30, 2024
guided $1.96 – $2.09
$1.08 Miss −46.7%
Reported diluted net earnings per common share Twelve Months Ending June 30, 2023
guided $2.62 – $2.76
$2.79 Beat +3.7%
Reported diluted net earnings per common share fiscal 2023 first quarter
guided $1.16 – $1.28
$1.35 Beat +10.7%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Neutral
1 · 4 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+12% Bullish
Price vs 50-day avg
−0% Neutral
RSI (14)
42 Neutral
MACD trend
Negative Bearish
52-week position
66% Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross) No cross
50d $102 › 200d $91 — 50d above 200d
Institutional flow Accumulating
+9% holders QoQ · +154 funds added
Insider flow Distributing
Net -$24.6M over 90 days · 100% sells
Short interest Falling
1.90% of shares out · ▼ -2.5% MoM · 1.9 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
917 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $67 Now $102 · 66% Range high $120
vs 200-day avg +12% vs 50-day avg 0%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
GAAP → non-GAAP reconciliation
GAAP Gross Margin 75.7%
+0% Restructuring and other activities
= Adjusted Gross Margin, Non-GAAP 75.7%
Adjusted Gross Profit, Non-GAAP non-GAAP 2.81B fiscal 2027 first quarter —
GAAP → non-GAAP reconciliation
GAAP Gross Profit $2.81B
+$1M Restructuring and other activities
= Adjusted Gross Profit, Non-GAAP $2.81B
Adjusted Gross Profit, Non-GAAP constant currency non-GAAP $2.81B Three Months Ended September 30, 2026 —
GAAP → non-GAAP reconciliation
Adjusted Gross Profit, Non-GAAP $2.81B (the result of another reconciliation in this filing)
-$8M Impact of foreign currency translation
= Adjusted Gross Profit, Non-GAAP constant currency $2.81B
GAAP → non-GAAP reconciliation
GAAP Operating Income $408M
+$41M Restructuring and other charges
= Adjusted Operating Income, Non-GAAP $449M
GAAP → non-GAAP reconciliation
Adjusted Operating Income, Non-GAAP $449M (the result of another reconciliation in this filing)
+$9M Impact of foreign currency translation
= Adjusted Operating Income, Non-GAAP constant currency $458M
GAAP → non-GAAP reconciliation
GAAP Operating Margin 11%
+1.1% Restructuring and other charges
= Adjusted Operating Margin, Non-GAAP 12.1%
Asia/Pacific Organic Net Sales (Non-GAAP) non-GAAP 10% fiscal 2027 first quarter —
consumer-facing investments 8% fiscal 2027 first quarter —
EUKEM operating margin 4.8% fiscal 2027 first quarter —
EUKEM Organic Net Sales (Non-GAAP) non-GAAP 4% fiscal 2027 first quarter —
Fragrance net sales 20% fiscal 2027 first quarter —
Free cash flow non-GAAP -$235M Three Months Ended September 30, 2026 —
GAAP → non-GAAP reconciliation
GAAP Net cash flows used for operating activities -$166M
-$69M Less: capital expenditures
= Free cash flow -$235M
Mainland China operating margin 5.2% fiscal 2027 first quarter —
Mainland China Organic Net Sales (Non-GAAP) non-GAAP 9% fiscal 2027 first quarter —
Makeup net sales 1% fiscal 2027 first quarter —
Organic Net Sales non-GAAP 6% fiscal 2027 first quarter —
Skin Care net sales 4% fiscal 2027 first quarter —
The Americas Organic Net Sales (Non-GAAP) non-GAAP 4% fiscal 2027 first quarter —
Adjusted Diluted Net Earnings Per Common Share, Non-GAAP non-GAAP $2.51 Twelve Months Ended June 30 —
Adjusted Diluted Net Earnings Per Common Share, Non-GAAP constant currency non-GAAP $2.47 Twelve Months Ended June 30 —
Adjusted Operating Income - Non-GAAP (fourth quarter) non-GAAP $267M fourth quarter fiscal 2026 —
Adjusted Operating Income - Non-GAAP (full year) non-GAAP $1.69B full-year fiscal 2026 —
Final net reduction in positions under PRGP restructuring program 10,000 full-year —
Full-year adjusted operating margin expansion non-GAAP 320 full-year fiscal 2026 —
Full-year gross margin expansion 150 full-year fiscal 2026 —
Mainland China adjusted operating income growth (full year) non-GAAP 92% full-year fiscal 2026 —
Mainland China organic net sales growth (full year) non-GAAP 9% full-year fiscal 2026 —
Restructuring charges recognized in fiscal 2026 fourth quarter $0.3B fourth quarter —
Restructuring charges recognized in fiscal 2026 full year $0.8B full-year —
Skin Care adjusted operating income (full year) non-GAAP $1.42B full-year fiscal 2026 —
Skin Care adjusted operating income growth (full year) non-GAAP 52% full-year fiscal 2026 —
Total cumulative charges under the restructuring component of the PRGP (through June 30, 2026) $1.4B cumulative through June 30, 2026 —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Household & Personal Products — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
EL
Estee Lauder Companies Inc
this stock
$36.87B -2.8% +5.0% 100.8 1.9%
PG
PROCTER & GAMBLE Co
$389.04B +17.1% +3.3% 25.3 1.0%
UL
Unilever PLC
$136.44B -3.1% — — 0.3%
CL
Colgate Palmolive Co
$77.01B +22.6% +1.7% 37.8 2.3%
RBGLY
Reckitt Benckiser Group PLC
$46.56B — — — 0.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
917
% held
62.6%
Net QoQ
-2.7M sh
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
767
View
Short & Settlement
Short Interest Falling
Shares short
6.9M
Days to cover
1.9d
Change
-179.5K sh
View
Short Volume
Short vol %
39%
As of
Nov 19, 2026
Short Total
View
Fails to Deliver
FTD shares
96
Value
$10.5K
As of
Oct 29, 2026
View
Off-Exchange
Off-exchange %
43.1%
Week of
Oct 12, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net selling
Net (90d)
-$24.6M
Buyers / Sellers
0 / 6
Buyers Sellers
View
Congressional Trades Buy
Member
Jonathan Jackson
Amount
$1.0K–$15.0K
Traded
Oct 12, 2026
View
Financials
Financials
Revenue (FY)
$15.0B
Net income (FY)
$182.0M
EPS diluted
$0.50
View
Buybacks
Remaining
shares 25.1M
View
Filings
SEC Filings
Latest
Investor Event Transcript
Filed
Nov 4, 2026
This year
22

Estee Lauder Companies reported first-quarter organic sales growth of 6% and expects fiscal 27 reported sales growth of 5% to 6.5% with operating margin of 12.9% to 13.7%.

View
Proposed Sales
Value
$467.8K
Shares
4.2K
Filed
Nov 13, 2026
View
Earnings & Events
Webcasts Upcoming
Next webcast
Feb 3, 2027
Last webcast
Nov 17, 2026
View
Investor Relations
Latest news
The Estée Lauder Companies 2026 A…
Published
Nov 10, 2026
Upcoming events
3
View

Performance

5D 20D 120D MTD YTD
EL -7.9% -5.5% +18.9% -6.8% -2.8%
SPY -5.5% -6.3% -5.6% -5.3% +5.0%
vs SPY -2.5% +0.8% +24.6% -1.6% -7.8%

Capital returns

Latest dividend
$0.35 / share · ex Aug 31, 2026
Declared · upcoming
$0.35 / share · ex Nov 30, 2026
Cut 47%
Paid (TTM)
$1.40 / share · 4 payouts
Dividend yield (TTM, derived)
1.38%
Full dividend history
Buyback program · as of Jun 30, 2026
Authorized
—
Spent (derived)
—
Remaining
shares 25.10M

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1001250 CUSIP 518439104 13F (30d) 883 filings 792 filers Visit website Investor relations